- AAIC: Lilly's solanezumab delays Alzheimer's progression by 34%
- Ready For The Big Biomarker Debate?
- Lilly investing in future, staying out of biotech 'bubble'
- Janssen/Genmab Win 1st Anti-CD38 In Multiple Myeloma
COMMENT Other Informa Comment
- Executive profile: the life and career of Genzyme CEO David Meeker
- Profile: Bruno Sepodes, Europe's Orphan Chief (AKA Batman), Who Loves Companies To Get Help
04 April 2016
06 April 2016
JOB OF THE WEEK Promote your job vacancy